Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Molecules (Basel, Switzerland)
|
February 19, 2016
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Valeria Famiglini, Romano Silvestri
Antiviral Chemistry & Chemotherapy
|
February 9, 2018
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Romano Silvestri
Molecules (Basel, Switzerland)
|
March 12, 2017
N-Pyrrylarylsulfones with High Therapeutic Potential
Valeria Famiglini, Sabrina Castellano, Romano Silvestri
ACS Combinatorial Science
|
March 22, 2012
Venting-while-heating microwave-assisted synthesis of 3-arylthioindoles
Giuseppe La Regina, Valerio Gatti, Valeria Famiglini, et al.
Future Medicinal Chemistry
|
November 23, 2013
Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Antonio Coluccia, Andrea Brancale, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 5, 2017
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities
Sveva Pelliccia, Yu-Hsuan Wu, Antonio Coluccia, et al.
Oncotarget
|
February 5, 2017
Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules
Erica Di Cesare, Annalisa Verrico, Andrea Miele, et al.
Plos One
|
February 4, 2014
An high-throughput in vivo screening system to select H3K4-specific histone demethylase inhibitors
Cecilia Mannironi, Marco Proietto, Francesca Bufalieri, et al.
Journal of Medicinal Chemistry
|
October 4, 2016
New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation
Antonio Coluccia, Sara Passacantilli, Valeria Famiglini, et al.
European Journal of Medicinal Chemistry
|
April 29, 2014
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Molecules (Basel, Switzerland)
|
February 19, 2016
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Valeria Famiglini, Romano Silvestri
Antiviral Chemistry & Chemotherapy
|
February 9, 2018
Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Romano Silvestri
Molecules (Basel, Switzerland)
|
March 12, 2017
N-Pyrrylarylsulfones with High Therapeutic Potential
Valeria Famiglini, Sabrina Castellano, Romano Silvestri
ACS Combinatorial Science
|
March 22, 2012
Venting-while-heating microwave-assisted synthesis of 3-arylthioindoles
Giuseppe La Regina, Valerio Gatti, Valeria Famiglini, et al.
Future Medicinal Chemistry
|
November 23, 2013
Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Antonio Coluccia, Andrea Brancale, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 5, 2017
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities
Sveva Pelliccia, Yu-Hsuan Wu, Antonio Coluccia, et al.
Oncotarget
|
February 5, 2017
Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules
Erica Di Cesare, Annalisa Verrico, Andrea Miele, et al.
Plos One
|
February 4, 2014
An high-throughput in vivo screening system to select H3K4-specific histone demethylase inhibitors
Cecilia Mannironi, Marco Proietto, Francesca Bufalieri, et al.
Journal of Medicinal Chemistry
|
October 4, 2016
New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation
Antonio Coluccia, Sara Passacantilli, Valeria Famiglini, et al.
European Journal of Medicinal Chemistry
|
April 29, 2014
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors
Valeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Page
of 3